Sonrai Analytics (Sonrai), a leading AI precision medicine company accelerating the development of therapeutics through advanced analytics, and Paige, a leader in next-generation AI technology, today announced a strategic partnership to better enable biopharma researchers, pathologists, and clinicians to harness cutting-edge AI capabilities for precision medicine research and development. By integrating Paige’s state-of-the-art foundation models with Sonrai’s intuitive cloud-based data analysis and bioinformatics platform, the partnership makes AI, machine learning, and multi-modal data integration accessible to non-technical users, creating the ability for more organizations to access a wide range of critical R&D needs without requiring deep AI expertise. This important collaboration will help bring a powerful set of solutions to the market that can accelerate drug discovery, biomarker identification, targeted therapeutics and precision medicine applications.

Burjeel Holdings, a leading super-specialty healthcare provider in the MENA region, has announced a strategic partnership with Paige, a US-based leader in next-generation AI technology. The collaboration aims to enhance access to advanced cancer diagnostics by deploying Paige’s AI-powered solutions across Burjeel’s healthcare network. It also seeks to address the global shortage of pathologists...